How have ABC shares performed in 2024?

Abcam's stock was trading at GBX 1,226 on January 1st, 2024. Since then, ABC shares have increased by 0.0% and is now trading at GBX 1,226. View the best growth stocks for 2024 here .

What other stocks do shareholders of Abcam own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN) , Xtrackers California Municipal Bond ETF (CA) , Endologix (ELGX) , BlackRock (BLK) , Chipotle Mexican Grill (CMG) , Aegean Marine Petroleum Network (ANW) , Athabasca Oil (ATH) , HSBC (HSBA) , Royal Dutch Shell (RDSA) and Centrica (CNA) .

How do I buy shares of Abcam?

Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:ABC

Abcam (ABC) Share Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free ABC Stock Alerts

GBX 1,226

+123.00 (+11.15%)

(As of 12/13/2022)

Compare

Today's Range: 1,115
▼
1,259
50-Day Range: 1,226
▼
1,226
52-Week Range: 1,013.57
▼
1,760

Volume: 6.37 million shs
Average Volume: 392,791 shs
Market Capitalization: £2.81 billion

P/E Ratio: 20,433.33
Dividend Yield: 0.91%
Price Target: N/A

Stock Analysis

Get Abcam alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Abcam Stock (LON:ABC)

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

ABC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ABC Stock News Headlines

April 19, 2024 | americanbankingnews.com

Abcam (LON:ABC) Share Price Crosses Below 200-Day Moving Average of $1,226.00

April 16, 2024 | msn.com

Researchers discover cause of rare congenital lung malformations

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

April 10, 2024 | americanbankingnews.com

Abcam (LON:ABC) Stock Passes Below Two Hundred Day Moving Average of $1,226.00

April 9, 2024 | finance.yahoo.com

DNA Methylation Market Analysis 2024-2032 by Product, Technology, Application, End User, and Region - Industry to Rise at a 13.9% CAGR

March 27, 2024 | finanznachrichten.de

Cell Culture Market Worth $57.9 billion | MarketsandMarkets

March 25, 2024 | uk.finance.yahoo.com

Global Research Antibodies Market Projected to Reach $5.5 Billion by 2030, Driven by Advances in Personalized Medicine

March 18, 2024 | sg.finance.yahoo.com

Super Micro Computer, Deckers Outdoor make S&P 500 debut

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

February 25, 2024 | msn.com

Bill Gates' 16 Dividend Stocks To Buy

February 21, 2024 | uk.finance.yahoo.com

3D Cell Cultures Market 2024-2028: Global Demand for 3D Cell Culture Solutions Surges with Expanding Biotechnology Applications

February 19, 2024 | msn.com

Why science parks are important

February 14, 2024 | finance.yahoo.com

Danaher Corporation: Reaffirming BUY, raising target to $285

February 5, 2024 | finanznachrichten.de

Recombinant Proteins Market Worth $3.2 Billion | MarketsandMarkets.

February 5, 2024 | uk.finance.yahoo.com

Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development

February 3, 2024 | seekingalpha.com

Danaher: Better Positioned For The Future

February 2, 2024 | finance.yahoo.com

Top Stock Reports for Eli Lilly, Danaher & Citigroup

February 1, 2024 | finanznachrichten.de

Lazard Reports Fourth-Quarter and Full-Year 2023 Results

January 30, 2024 | finanznachrichten.de

Danaher Corporation: Danaher Reports Fourth Quarter and Full Year 2023 Results

January 30, 2024 | reuters.com

Danaher forecasts revenue decline in 2024, shares fall

January 29, 2024 | msn.com

Another UK snub: Cambridge spin-out eyes New York IPO as unicorn status beckons

January 26, 2024 | bizjournals.com

Here's how a bite-sized merger deal between two Reston-based contractors benefitted both

January 23, 2024 | finance.yahoo.com

Research Antibodies Global Market Analysis to 2030: Focus on Monoclonal Antibodies, Rising Demand in North America, Strategies of Leading Players

January 23, 2024 | ca.finance.yahoo.com

DHR Sep 2024 210.000 call

January 19, 2024 | finance.yahoo.com

Danaher Corporation (DHR) Completed the Acquisition of Abcam

January 14, 2024 | uk.finance.yahoo.com

Abcam PLC (A8C3.MU)

January 9, 2024 | finanznachrichten.de

Danaher Corporation: Danaher CEO to Comment on Financial Performance

See More Headlines

Receive ABC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:ABC
CUSIP: N/A
CIK: N/A
Web: www.abcam.com
Phone: +44-1223-696000
Fax: N/A
Employees: 1,650
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 20,433.33
Forward P/E Ratio: 33.28
P/E Growth: 1.57
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 31.60
Current Ratio: 1.27
Quick Ratio: 0.89

Sales & Book Value

Annual Sales: £350.40 million
Price / Sales: 8.02
Cash Flow: GBX 50.93 per share
Price / Cash Flow: 24.07
Book Value: GBX 318.30 per share
Price / Book: 3.85

Miscellaneous

Outstanding Shares: 229,272,000
Free Float: N/A
Market Cap: £2.81 billion
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Alan Thomas Hirzel BS (Age 54)
M.B.A., M.S., MBA, MS, CEO & Exec. Director
Comp: $1.23M
Mr. Michael Shaun Baldock B.A. (Age 58)
CFO & Director
Comp: $881.14k
Mr. Mark Dermody
Interim CIO
James Staveley
VP of Investor Relations
Marc Perkins
Gen. Counsel & Company Sec.
Emma Sceats
Sr. VP of Sales, Service & Bus. Devel.
Mr. Nick Skinner
Sr. VP of HR
Mr. Mark Bushfield
Sr. VP of Research & Innovation
Ms. Kirstie Speck BBusSc
Head of Consumer Insights
Ms. Yvonne Chien
Sr. VP of Customer Experience

Key Competitors

View All Competitors

ABC Stock Analysis - Frequently Asked Questions

How have ABC shares performed in 2024?: Abcam's stock was trading at GBX 1,226 on January 1st, 2024. Since then, ABC shares have increased by 0.0% and is now trading at GBX 1,226.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Abcam own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), HSBC (HSBA), Royal Dutch Shell (RDSA) and Centrica (CNA).
How do I buy shares of Abcam?: Shares of ABC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ABC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial